Related Experiment Videos
Low flow after global ischemia to improve postischemic myocardial function and bioenergetics
Paul F Klawitter1, Holt N Murray, Thomas L Clanton
1Department of Emergency Medicine, The Ohio State University, Columbus, OH 43210, USA.
Critical Care Medicine
|November 21, 2002
Summary
A period of low flow perfusion after global ischemia, but before full reperfusion, can improve heart function and energy recovery. However, very low flow may hinder recovery compared to continuous ischemia.
Area of Science:
- Cardiovascular physiology
- Ischemic heart disease research
- Myocardial bioenergetics
Background:
- Global ischemia can lead to impaired ventricular function and energy depletion.
- Understanding protective strategies during reperfusion is crucial for cardiac recovery.
Purpose of the Study:
- To investigate if a period of low flow perfusion before full reperfusion enhances post-ischemic ventricular function and bioenergetics.
- To determine the optimal level of low flow for myocardial recovery.
Main Methods:
- Prospective, randomized, controlled animal study using Sprague-Dawley rats.
- Hearts underwent 15 minutes of global ischemia followed by 5 minutes of low flow (10% or 1% of baseline) or no flow (control).
- Left ventricular function and myocardial metabolite concentrations (e.g., adenosine triphosphate) were measured.
Main Results:
- A 10% low flow perfusion significantly improved left ventricular function and bioenergetics compared to 0% or 1% flow.
- 1% low flow perfusion did not improve function and led to decreased adenosine triphosphate levels during reperfusion compared to no flow.
- Adenosine triphosphate levels were 9.4 ± 1.0 μmol/g dry weight at 1% flow versus 13.2 ± 1.0 μmol/g dry weight with no flow (p < .01).
Conclusions:
- A specific level of low flow perfusion before reperfusion can improve post-ischemic myocardial function and energetic recovery.
- Insufficient low flow (1%) may impair bioenergetic recovery without functional improvement, potentially worsening outcomes compared to continuous global ischemia.